Skip to main content

Obstetrics and gynaecology

Obstetrics and gynaecology

19-02-2018 | Gynaecological cancer | News | Article

Chemoradiotherapy benefits demonstrated in locally advanced cervical cancer

Cisplatin chemoradiotherapy significantly delays disease recurrence and improves survival compared with radiotherapy alone in women with stage IIIB squamous cell carcinoma of the cervix, phase III study data show.

14-12-2017 | Breast cancer | News | Article

Short-term GnRHa therapy may prevent breast cancer chemotherapy-related ovarian dysfunction

Temporary ovarian suppression with a gonadotropin-releasing hormone analog alongside neoadjuvant or adjuvant chemotherapy could help preserve ovarian function and fertility in premenopausal women with early-stage breast cancer, shows a pooled analysis.

11-08-2017 | Gynaecological cancer | News | Article

Olaparib tablets improve PFS in BRCA1/2 mutated relapsed ovarian cancer

Maintenance therapy with olaparib, given in the newer tablet formulation, significantly improves progression-free survival compared with placebo in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation, phase III trial data show.

Pregnant woman_grey background

27-07-2017 | HBV | News | Article

Maternal HBV infection raises preterm birth risk

Women with hepatitis B virus infection prior to becoming pregnant are significantly more likely to have a preterm birth than those without HBV, shows an analysis of a Chinese population-based cohort.

Pregnancy with Doctor

04-07-2017 | Rheumatology | News | Article

Increased surveillance recommended for pregnant women with JIA

Women with a juvenile idiopathic arthritis diagnosis are at increased risk for both maternal and infant complications during pregnancy and birth, show data from a nationwide Swedish study.

10-04-2017 | Oncology | News | Article

Surveillance warranted for pregnancies in adolescent, young adult cancer survivors

Adverse birth outcomes, specifically preterm births and infants with low birth weight, are more likely among adolescent and young adult cancer survivors than women without cancer, a US study shows.

Pregnant woman_grey background

20-03-2017 | Oncology | News | Article

Maternal, fetal outcomes of pregnancy in cancer in focus

Two independent studies shed light on the effects of pregnancy during cancer, one finding that pregnancy does not adversely affect the survival of women with breast cancer and the other showing an association between maternal cancer and an increased risk for stillbirth and neonatal mortality.

Doctor studying scan

23-01-2017 | Neurology | News | Article

Volume and location key to predicting preterm neonate WM injury outcomes

Predicting adverse motor and cognitive outcomes in preterm neonates with white matter injury requires the mapping of both lesion volume and location, suggests a magnetic resonance imaging study.

Pregnant woman_pharmacy

18-01-2017 | Neurology | News | Article

Folic acid supplement recommendation for neural tube defects upheld

The US Preventive Services Task Force has reaffirmed its 2009 recommendation that women who are planning or capable of pregnancy should take a daily supplement containing 400 µg to 800 µg of folic acid for the prevention of neural tube defects.

08-12-2016 | Multiple sclerosis | News | Article

Newborn vitamin D status linked to future MS risk

Babies born with low levels of vitamin D may be at increased risk for multiple sclerosis in later life, suggests research.

11-11-2016 | Diabetes | News | Article

Maternal iron stores linked to gestational diabetes risk

Pregnant women with high iron stores may be at an increased risk for developing gestational diabetes, a study suggests.

08-11-2016 | Diabetes | News | Article

Gestational diabetes vascular risk not solely down to type 2 diabetes development

Women with gestational diabetes have a subsequent increased risk for adverse macrovascular outcomes, even if they never develop type 2 diabetes, report researchers.

Mansoor Raza Mirza

18-10-2016 | Gynaecological cancer | News | Article

Niraparib maintenance ‘warranted’ for platinum-sensitive recurrent ovarian cancer

ENGOT-OV16/NOVA trial results support the use of maintenance treatment with niraparib for platinum-sensitive recurrent ovarian cancer, in both patients with and without a germline BRCA mutation.

14-10-2016 | Diabetes | News | Article

HbA1c flags postpartum diabetes risk after gestational diabetes

Research suggests that women with gestational diabetes who have elevated glycated haemoglobin levels in the third trimester of pregnancy should be closely monitored for the development of diabetes after delivery.

14-10-2016 | HBV | News | Article

Close monitoring of pregnant HBV patients warranted

Pregnant women with chronic hepatitis B virus infection can experience flares in HBV DNA and serum alanine aminotransferase levels during pregnancy and postpartum, research shows.

Pipette_rack with samples

06-10-2016 | Oncology | News | Article

Spotlight on cervical cancer screening recommendations

Two articles present information to support upcoming and potential changes to cervical cancer screening guidelines.

07-09-2016 | Diabetes | News | Article

Predictive models for gestational diabetes ranked

Dutch researchers have assessed the ability of 12 published models to predict gestational diabetes in a large cohort of women.

Pregnant woman_grey background

18-08-2016 | Diabetes | News | Article

Closed-loop insulin delivery success in pregnancy

Overnight closed-loop insulin delivery maintains tighter control of glucose levels than sensor-augmented pump delivery in pregnant women with Type 1 diabetes, shows a randomised crossover trial.

12-08-2016 | Cardiology | News | Article

Aortic complications fourfold higher during pregnancy

The risk of aortic dissection or rupture is elevated fourfold during pregnancy and the postpartum period, results of a large, population-based study show.


21-07-2016 | Breast cancer | News | Article

Breast cancer risk reassurance for IVF-treated women

Women who receive in vitro fertilisation treatment do not have a higher risk of developing breast cancer in the long term versus those who receive non-IVF therapy and the general population, say Dutch researchers.